Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Lowey reintroduces sunscreen monograph bill

This article was originally published in The Tan Sheet

Executive Summary

Rep. Nita Lowey, D-N.Y., reintroduces the Skin Cancer Prevention, Education, and Consumer Right-To-Know Act April 23. The bill, H.R. 2088, would give FDA 180 days to finalize its long-awaited monograph for broad-spectrum sunscreen ingredients that protect consumers from both UVA and UVB rays. The legislation, similar to a bill Lowey introduced in the previous Congress, would also require the Department of Health and Human Services to initiate a nationwide education campaign on the importance of sunscreen application (1"The Tan Sheet" Dec. 15, 2008, p. 12). The legislation was referred to the House Energy and Commerce Committee

You may also be interested in...

Dodd reintroduces sunscreen monograph bill

Dr. Reddy' creating group of about 30 scientists to focus on proprietary product development, responsible for building the branded R&D portfolio in collaboration with partners and service providers.Sen. Chris Dodd, D-Conn., reintroduces legislation imposing a 180-day deadline on FDA to finalize the monograph for broad-spectrum sunscreen ingredients that shield UVA and UVB rays (see story p. 10). The Sunscreen Labeling Protection Act, S. 1112, co-authored by Rhode Island Democrat Jack Reed, was referred May 20 to the Health, Education, Labor and Pensions Committee. Rep. Nita Lowey, D-N.Y., in April reintroduced a House

Congresswoman, Pageant Winner Back Petition For Final Sunscreen Regs

A consumer advocacy group gets support from a member of Congress and a beauty pageant winner as well as industry stakeholders for its citizen petition to light a fire under FDA about making state-of-the-art, broad-spectrum sunscreens available in the U.S

US FDA Addresses PFAS In Cosmetics, Aiming To Close Data Gaps

Use of per- and polyfluoroalkyl substances in cosmetic products appears to be declining, based on voluntary industry registrations with the US Food and Drug Administration. In any event, NGOs are gunning for PFAS' elimination, and the FDA says available data have yet to give a complete safety picture for PFAS used intentionally in cosmetics or present as impurities.





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts